Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping

[1]  P. Jänne,et al.  Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung Cancer. , 2016, JAMA oncology.

[2]  C. Verschraegen,et al.  Successful Treatment of Non-Small Cell Lung Cancer With Erlotinib Throughout Pregnancy. , 2015, JAMA oncology.

[3]  Lucio Crinò,et al.  Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Broutin,et al.  Variation in transplacental transfer of tyrosine kinase inhibitors in the human perfused cotyledon model. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  S. Broutin,et al.  Efficacy and safety of gefitinib during pregnancy: case report and literature review. , 2014, Lung cancer.

[6]  William Pao,et al.  Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. , 2014, JAMA.

[7]  N. Pavlidis,et al.  Lung cancer in pregnancy: report of nine cases from an international collaborative study. , 2013, Lung cancer.

[8]  N. Pavlidis,et al.  Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Nesrin Sarıman,et al.  Lung cancer and pregnancy. , 2013, Lung cancer.

[10]  C. Bonilla,et al.  Use of erlotinib throughout pregnancy: a case-report of a patient with metastatic lung adenocarcinoma. , 2012, Lung cancer.

[11]  C. Liam,et al.  Successful pregnancy with epidermal growth factor receptor tyrosine kinase inhibitor treatment of metastatic lung adenocarcinoma presenting with respiratory failure. , 2011, Lung cancer.

[12]  Jeffrey W. Clark,et al.  Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. , 2011, The Lancet. Oncology.

[13]  N. Pavlidis,et al.  Lung cancer in the pregnant woman: to treat or not to treat, that is the question. , 2010, Lung cancer.

[14]  S. Digumarthy,et al.  Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Zambelli,et al.  Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy. , 2008, Lung cancer.

[16]  N. Pavlidis.  Lung cancer during pregnancy: an emerging issue. , 2008, Lung cancer.

[17]  P. Jänne,et al.  Chemotherapy for a Patient with Advanced Non-Small-Cell Lung Cancer during Pregnancy: A Case Report and a Review of Chemotherapy Treatment during Pregnancy , 2001, Oncology.

[18]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[19]  P. Mota,et al.  Lung cancer during pregnancy: an unusual case. , 2014, Revista portuguesa de pneumologia.

[20]  P. C. Mota,et al.  Cancro do pulmão durante a gravidez: um caso incomum , 2014 .

[21]  K. Howdeshell.  NTP Monograph: Developmental Effects and Pregnancy Outcomes Associated With Cancer Chemotherapy Use During Pregnancy. , 2013, NTP monograph.

[22]  A. Tsao,et al.  ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers , 2012 .

[23]  N. Pavlidis,et al.  Gastrointestinal, urologic and lung malignancies during pregnancy. , 2008, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[24]  R. Greene,et al.  Lung cancer and pregnancy. , 1985, Der Radiologe.